ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,532Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 910

$444K Total Retail Price of All Prescriptions

Rank: 227 out of 910

448 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

5% of this provider’s 9,473 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 813 653 1 1
LISINOPRIL 490 392 2 2
AMLODIPINE BESYLATE 439 380 3 4
SIMVASTATIN 414 337 4 3
METFORMIN HCL 389 290 5 6
PRAVASTATIN SODIUM 378 322 6 16
HYDROCODONE-ACETAMINOPHEN 285 239 S3 7 8
OMEPRAZOLE 276 219 8 5
METOPROLOL TARTRATE 266 249 9 7
LOVASTATIN 254 209 10 20
GLYBURIDE 251 207 R 11 46
FUROSEMIDE 225 192 12 9
ATENOLOL 202 164 13 10
OXYCODONE-ACETAMINOPHEN 200 142 S2 14 31
HYDROCHLOROTHIAZIDE 194 158 15 12
ROPINIROLE HCL 172 159 16 119
OXYCODONE HCL-ACETAMINOPHEN 164 142 S2 17 114
ALENDRONATE SODIUM 148 126 18 22
ATORVASTATIN CALCIUM 147 119 19 14
LOSARTAN POTASSIUM 146 135 20 15
MELOXICAM 134 124 21 76
CLOPIDOGREL 128 107 22 35
TAMSULOSIN HCL 124 107 23 29
RANITIDINE HCL 119 105 24 28
GLIPIZIDE 119 86 24 38
LOSARTAN-HYDROCHLOROTHIAZIDE 117 98 26 79
WARFARIN SODIUM 110 100 27 11
POTASSIUM CHLORIDE 100 100 28 18
INSULIN SYRINGE 97 71 29 47
BENICAR 95 81 30 94
PREDNISONE 94 74 31 43
GABAPENTIN 90 76 32 13
LANTUS 84 56 33 30
CARVEDILOL 84 83 33 36
PANTOPRAZOLE SODIUM 79 71 35 27
NIFEDIPINE ER 79 63 35 107
CARISOPRODOL 78 44 R 37 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 62 38 44
PAROXETINE HCL 76 38 39 50
PLAVIX 75 62 40 53
CYCLOBENZAPRINE HCL 74 63 R 41 80
MORPHINE SULFATE ER 67 49 S2 42 52
IBUPROFEN 67 42 42 75
CAPTOPRIL 64 64 44 187
FLUTICASONE PROPIONATE 61 46 45 23
BENAZEPRIL HCL 60 46 46 89
ACTONEL 58 55 47 102
AZITHROMYCIN 56 47 48 41
DICYCLOMINE HCL 55 55 49 260
AMITRIPTYLINE HCL 52 23 R 50 72
DIGOXIN 51 51 51 64
FINASTERIDE 50 50 52 59
NIFEDIAC CC 50 32 52 131
ACTOS 50 50 52 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.